These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 18090276

  • 1. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
    Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.
    AIDS; 2007 Nov 12; 21(17):2283-91. PubMed ID: 18090276
    [Abstract] [Full Text] [Related]

  • 2. Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis.
    Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, van Dam GJ, Deelder AM, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.
    Am J Trop Med Hyg; 2008 Sep 12; 79(3):331-7. PubMed ID: 18784223
    [Abstract] [Full Text] [Related]

  • 3. Cytokine expression during syphilis infection in HIV-1-infected individuals.
    Knudsen A, Benfield T, Kofoed K.
    Sex Transm Dis; 2009 May 12; 36(5):300-4. PubMed ID: 19265730
    [Abstract] [Full Text] [Related]

  • 4. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH.
    J Gastroenterol Hepatol; 2006 Jul 12; 21(7):1163-9. PubMed ID: 16824070
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM, Lima PG, Filho RG, Hygino J, Milczanowski SF, Andrade AF, Lauria C, Brindeiro R, Tanuri A, Bento CA.
    AIDS; 2007 Aug 20; 21(13):1763-70. PubMed ID: 17690575
    [Abstract] [Full Text] [Related]

  • 6. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec 20; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 7. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, Gouillou M, Schlub TE, Davenport M, Crowe S, Elliott J, Hoy J, Fairley C, Stewart G, Cameron P, Lewin SR.
    J Infect Dis; 2010 Oct 15; 202(8):1254-64. PubMed ID: 20812848
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.
    Shrestha S, Wang C, Aissani B, Wilson CM, Tang J, Kaslow RA.
    Cancer Epidemiol Biomarkers Prev; 2007 Aug 15; 16(8):1626-32. PubMed ID: 17684137
    [Abstract] [Full Text] [Related]

  • 9. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.
    Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, Conant K, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Marder K, Epstein LG.
    Arch Neurol; 2007 Jan 15; 64(1):97-102. PubMed ID: 17210815
    [Abstract] [Full Text] [Related]

  • 10. Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.
    Boulassel MR, Smith GH, Edwardes MD, Young M, Klein M, Gilmore N, Macleod J, Leblanc R, René P, Allan J, Lalonde RG, Routy JP.
    HIV Med; 2005 Jul 15; 6(4):268-77. PubMed ID: 16011532
    [Abstract] [Full Text] [Related]

  • 11. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR, Dawes PT, Nixon NB, Mattey DL.
    Arthritis Res Ther; 2005 Jul 15; 7(6):R1227-34. PubMed ID: 16277675
    [Abstract] [Full Text] [Related]

  • 12. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I.
    Clin Infect Dis; 2008 Jun 15; 46(12):1902-10. PubMed ID: 18462177
    [Abstract] [Full Text] [Related]

  • 13. Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.
    Haas DW, Geraghty DE, Andersen J, Mar J, Motsinger AA, D'Aquila RT, Unutmaz D, Benson CA, Ritchie MD, Landay A, AIDS Clinical Trials Group.
    J Infect Dis; 2006 Oct 15; 194(8):1098-107. PubMed ID: 16991084
    [Abstract] [Full Text] [Related]

  • 14. Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency.
    Cataldo F, Lio D, Marino V, Scola L, Crivello A, Mulè AM, Corazza GR, Groups of the SIGEP and "Club del Tenue".
    Am J Gastroenterol; 2003 Apr 15; 98(4):850-6. PubMed ID: 12738467
    [Abstract] [Full Text] [Related]

  • 15. Time-dependence of survival predictions based on markers of HIV disease. Swiss HIV Cohort Study.
    Perneger TV, Abrahamowicz M, Bartlett G, Yerly S.
    J Investig Med; 2000 May 15; 48(3):207-12. PubMed ID: 10822902
    [Abstract] [Full Text] [Related]

  • 16. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 15; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 17. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D, Spritzler J, Grossberg SE, Fahey JL, Johnston DM, Schock BR, Kagan J.
    Clin Infect Dis; 2005 Mar 15; 40(6):853-8. PubMed ID: 15736019
    [Abstract] [Full Text] [Related]

  • 18. Genetic determinants of circulating levels of tumor necrosis factor receptor II and their association with TNF-RII gene polymorphisms.
    Vistoropsky Y, Ermakov S, Toliat MR, Trofimov S, Altmüller J, Malkin I, Nürnberg P, Livshits G.
    Cytokine; 2010 Jul 15; 51(1):28-34. PubMed ID: 20488723
    [Abstract] [Full Text] [Related]

  • 19. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus.
    Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, Daikoku M, Yatsuhashi H, Koga M, Yano M, Eguchi K.
    Am J Gastroenterol; 2002 Aug 15; 97(8):2086-92. PubMed ID: 12190181
    [Abstract] [Full Text] [Related]

  • 20. Impact of acute vivax malaria on the immune system and viral load of HIV-positive subjects.
    Chen X, Xiao B, Shi W, Xu H, Gao K, Rao J, Zhang Z.
    Chin Med J (Engl); 2003 Dec 15; 116(12):1810-20. PubMed ID: 14687465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.